Single Nucleotide Polymorphisms in Regulator-Encoding Genes Have an Additive Effect on Virulence Gene Expression in a Vibrio cholerae Clinical Isolate.
Vibrio cholerae is the etiological agent of the infectious disease cholera, which is characterized by vomiting and severe watery diarrhea. Recently, V. cholerae clinical isolates have demonstrated increased virulence capabilities, causing more severe symptoms with a much higher rate of disease progression than previously observed. We have identified single nucleotide polymorphisms (SNPs) in four virulence-regulatory genes (hapR, hns, luxO, and vieA) of a hypervirulent V. cholerae clinical isolate, MQ1795. Herein, all SNPs and SNP combinations of interest were introduced into the prototypical El Tor reference strain N16961, and the effects on the production of numerous virulence-related factors, including cholera toxin (CT), the toxin-coregulated pilus (TCP), and ToxT, were analyzed. Our data show that triple-SNP (hapR hns luxO and hns luxO vieA) and quadruple-SNP combinations produced the greatest increases in CT, TCP, and ToxT production. The hns and hns luxO SNP combinations were sufficient for increased TCP and ToxT production. Notably, the hns luxO vieA triple-SNP combination strain produced TCP and ToxT levels similar to those of MQ1795. Certain SNP combinations (hapR and hapR vieA) had the opposite effect on CT, TCP, and ToxT expression. Interestingly, the hns vieA double-SNP combination strain increased TCP production while decreasing CT production. Our findings suggest that SNPs identified in the four regulatory genes, in various combinations, are associated with increased virulence capabilities observed in V. cholerae clinical isolates. These studies provide insight into the evolution of highly virulent strains. IMPORTANCE Cholera, an infectious disease of the small intestine caused by the aquatic bacterium Vibrio cholerae, often results in vomiting and acute watery diarrhea. If left untreated or if the response is too slow, the symptoms can quickly lead to extreme dehydration and ultimately death of the patient. Recent anecdotal evidence of cholera patients suffering from increasingly severe symptoms and of disease progression at a much higher rate than previously observed has emerged. As recent cholera outbreaks caused by increasingly virulent strains have resulted in higher mortality rates, the need to investigate the mechanism(s) allowing this observed increased virulence is apparent. The significance of our research is in identifying the mechanism for increased virulence capabilities, which will allow the development of a model that will greatly enhance our understanding of cholera disease and V. cholerae pathogenesis, leading to broader biomedical impacts, as cholera serves as a model for other enteric diarrheal diseases.
Department of Biological Sciences, Plymouth State University, Plymouth, New Hampshire, USA.
Bailey M
BM
Carignan
Department of Biological Sciences, Plymouth State University, Plymouth, New Hampshire, USA.
Kyle D
KD
Brumfield
Department of Biological Sciences, Plymouth State University, Plymouth, New Hampshire, USA.
Mike S
MS
Son
Toxin-coregulated pilus; Vibrio cholerae; cholera toxin; hapR; hns; luxO; toxT; vieA; virulence factors
MBio. 2010 May 18;1(1):null
20689747
J Clin Microbiol. 2002 Jan;40(1):172-81
11773113
Methods Enzymol. 1994;235:517-26
8057923
Microbiol Immunol. 1986;30(11):1075-83
3543624
Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5403-7
2052618
J Bacteriol. 2000 Aug;182(15):4295-303
10894740
J Bacteriol. 2011 Feb;193(4):979-88
21169492
Gene. 1996 Feb 22;169(1):47-52
8635748
Mol Microbiol. 2002 Nov;46(4):1135-47
12421317
Mol Microbiol. 1994 May;12(3):403-12
8065259
Infect Immun. 2003 May;71(5):2571-6
12704130
Environ Microbiol Rep. 2011 Apr;3(2):218-222
21643457
J Bacteriol. 2011 Oct;193(19):5260-70
21804008
J Clin Microbiol. 2002 Sep;40(9):3296-9
12202569
Mol Microbiol. 2000 Oct;38(1):67-84
11029691
Infect Immun. 2005 Sep;73(9):5873-82
16113306
J Bacteriol. 1999 Jul;181(14):4250-6
10400582
J Bacteriol. 1995 Jun;177(11):3191-8
7768818
J Clin Microbiol. 2004 Dec;42(12):5854-6
15583324
Mol Microbiol. 2003 Jul;49(1):81-92
12823812
Lancet. 1983 Apr 9;1(8328):805-7
6132141
Mol Microbiol. 2001 Jul;41(2):393-407
11489126
Lancet. 1993 Mar 13;341(8846):704
8095621
J Med Microbiol. 2006 Nov;55(Pt 11):1559-62
17030916
Proc Natl Acad Sci U S A. 1987 May;84(9):2833-7
2883655
Mol Microbiol. 2004 Aug;53(3):857-69
15255898
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3129-34
11854465
J Bacteriol. 1992 Nov;174(21):6974-80
1400247
J Clin Microbiol. 1982 Jul;16(1):129-34
7107852
Science. 1996 Jun 28;272(5270):1910-4
8658163
Methods Enzymol. 1994;235:386-405
8057911
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3134-9
9501228
Kansenshogaku Zasshi. 1997 Oct;71(10):1037-45
9394556
J Med Microbiol. 2006 Nov;55(Pt 11):1563-9
17030917
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):730-4
9435261
J Clin Microbiol. 2010 Nov;48(11):4283-6
20810767
J Exp Med. 1988 Oct 1;168(4):1487-92
2902187
Emerg Infect Dis. 2004 Nov;10(11):2057-9
16010751
Int J Med Microbiol. 2007 Oct;297(6):443-9
17475554
Infect Immun. 2001 Mar;69(3):1947-52
11179381
Annu Rev Genet. 1994;28:117-39
7893120
Annu Rev Microbiol. 2001;55:165-99
11544353
Appl Environ Microbiol. 2012 Apr;78(7):2482-8
22287003
J Bacteriol. 2002 Aug;184(15):4104-13
12107127
Cell. 2002 Aug 9;110(3):303-14
12176318
J Clin Microbiol. 2011 Nov;49(11):3739-49
21880975